Hepatitis A virus vaccine (Biolotus Biotech)

甲型肝炎病毒疫苗

Report date: 2022/01/14 13:23:58

Base Information

Drug NameHepatitis A virus vaccine (Biolotus Biotech)

Drug Alias NameZyvak-A

ClassificationVaccines > Application > Prophylactic vaccineVaccines > Biological material > Viral vaccineVaccines > Development/production technology > Live attenuated vaccine

Mechanisms of ActionImmunostimulants

TargetsNot applicable

Therapy Area/IndicationsHepatitis A

Global Approved IndicationsHepatitis A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryBrazil

Original Approved Date2015/07/01

Country/TerritoryBrazil

CombinationsNo

Global Highest StatusApproved

Highest Status in ChinaN/A

Originator CompaniesBiolotus

China Registration ClassN/A

Develop Information

Active CompaniesBiolotus

Inactive CompaniesN/A

Active IndicationsHepatitis A

Inactive IndicationsN/A

Other Information

ATC CodeJ07BC